Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-24 · accession 0001728117-24-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-25 | 2024-06-24 | GOSS | Aranda Richard | Chief Medical Off | S - Sale | $0.66 | -1,908 | 196.9K | -1.0% | -$1,259 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-24 | S | D | 1,908 | $0.66 | 196,891 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |